[Clinical effectiveness and safety of paroxetine in post-stroke depression: results from a phase 4, open label, multicenter clinical trial with 26 weeks of follow-up].

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples